Engineers Gate Manager LP

Position in ARCT — Arcturus Therapeutics Holdings Inc.

CIK 1620220 NEW YORK, NY

Position in ARCT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$193,320

-$160,510 QoQ

Shares Held

28,768

-37.2% QoQ

Ownership

0.101%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#56

of 133 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $195,993,154 across 162 Biotechnology names. ARCT ranks #128 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$193,320	28,768	-37.2%	Shares	Sole	2026-08-14
2026-03-31	$353,830	45,833	-32.8%	Shares	Sole	2026-05-15
2025-12-31	$417,943	68,180	+287.1%	Shares	Sole	2026-02-17
2023-06-30	$505,112	17,612	+69.5%	Shares	Sole	2023-08-14
2023-03-31	$249,048	10,390	-65.1%	Shares	Sole	2023-05-15
2021-06-30	$1,006,706	29,749	+77.9%	Shares	Sole	2021-08-16
2021-03-31	$690,742	16,725	+59.0%	Shares	Sole	2021-05-17
2020-12-31	$456,227	10,517	-34.9%	Shares	Sole	2021-02-16
2020-06-30	$755,505	16,164	-27.9%	Shares	Sole	2020-08-17
2020-03-31	$304,633	22,416	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.